Author:
Khangembam Cherita Devi,Niveria Karishma,Priyadarshani Anjali
Publisher
Springer Nature Singapore
Reference68 articles.
1. Aguiar ACC, Parisi JR, Granito RN, de Sousa LRF, Renno ACM, Gazarini ML (2021) Metabolites from marine sponges and their potential to treat malarial protozoan parasites infection: a systematic review. Mar Drugs 19(3):134. https://doi.org/10.3390/md19030134
2. Alamgir A (2018) Bioactive compounds and pharmaceutical excipients derived from animals, marine organisms, microorganisms, minerals, synthesized compounds, and pharmaceutical drugs. In: Therapeutic use of medicinal plants and their extracts: volume 2. Springer, Cham, pp 311–406
3. Ang KK, Holmes MJ, Higa T, Hamann MT, Kara UA (2000) In vivo antimalarial activity of the beta-carboline alkaloid manzamine A. Antimicrob Agents Chemother 44(6):1645–1649. https://doi.org/10.1128/aac.44.6.1645-1649.2000
4. Aversi-Ferreira R, Galvão JD, da Silva SF, Cavalcante GF, da Silva EV, Bhatia-Dey N et al (2014) Geographical and environmental variables of leishmaniasis transmission. IntechOpen, London
5. Balunas MJ, Linington RG, Tidgewell K, Fenner AM, Ureña L-D, Togna GD et al (2010) Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity. J Nat Prod 73(1):60–66. https://doi.org/10.1021/np900622m